Alterity Therapeutics Limited ( ATHE) - Stock Earnings
ATHE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 28, 2026, midnight | — / — | — | — / — | — |
ATHE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.4 million USD | 1.3 million USD |
| 2024Q1 | -2.7 million USD | 451223 USD |
| 2024Q2 | -8.4 million USD | 1.4 million USD |
ATHE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -8.9 million USD | 3.5 million USD |
| 2023 | -9.2 million USD | 2.6 million USD |
| 2024 | -12.8 million USD | 2.7 million USD |
ATHE
Price: $4.79
52 week price:
Earnings Per Share: -0.59 USD
P/E Ratio: -5.97
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 8900
Market Capitalization: 75.4 million